University of Cambridge > Talks.cam > Computational and Systems Biology > Genome-Based Drug Discovery and Re-Purposing: a new golden age for DNA microarrays?

  Browse A-Z

Log in

Cambridge users (raven)details Other usersdetails No account?details

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

Genome-Based Drug Discovery and Re-Purposing: a new golden age for DNA microarrays?

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Danielle Stretch.

A large number of recent studies wink at the idea that every biological state can be described by a proper gene expression signature: a well defined set of genes together with a pattern of expression linked to it. The underlying concepts are: i) any condition,(e.g. the activity of a given pathway, a disease phenotype or cellular response to drug treatment), induces some change in transcriptional activity; ii) even if a single gene on its own poorly characterizes a biological state of interest, this ability is significantly improved when considering a set of genes with their combined pattern of expression.

In this scenario DNA micro-array technology can be deemed as the natural language through which these “biological-state-summaries” can be generated. Using novel non-parametric genome-wide metrics, novel drug-to-disease and/or drug-to-drug “connections” have been predicted comparing the corresponding gene-expression signatures. Several approaches have been proposed to exploit the massive amount of publicly available gene-expression data for computational “drug re-purposing” (i.e. predicting new therapeutic applications for already existing drugs).

In contrast with these methods (very good predictors but providing limited mechanistic insight), transcriptomic data following drug treatment have been integrated with pathway maps and protein-protein-interaction networks to infer upstreaming molecular events, thereby dissecting the mechanisms involved in drug-response. ! We will describe a number of approaches based on the introduced concepts, highlighting pros and cons of each classes of methods. Finally, we will present some successful case studies and useful public available tools and resources.

The talk is part of the CCBI seminar series and the DTP graduate course Reviews in Computational Biology, but is open to all attendees.

This talk is part of the Computational and Systems Biology series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

South Asia Film Series Cambridge University First Aid Society Brain Training: secrets, drugs and analysis.

Other talks

Autumn Cactus & Succulent Show Ancient DNA studies of early modern humans and late Neanderthals Algorithmic Investigation of Large Biological Data sets Open as a Tool to Change Ecosystems How could education systems research prompt a change to how DFIS works on education Imaging techniques and novel tools for early detection and intervention Cambridge Rare Disease Summit 2017 Disease Migration Singularities of Hermitian-Yang-Mills connections and the Harder-Narasimhan-Seshadri filtration TBC Fields of definition of Fukaya categories of Calabi-Yau hypersurfaces Carers and Careers: The Impact of Caring on Academic Careers
 

© 2006-2024 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity